NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

Children’s Hospital Introduces Technology to Combat HAIs

There is a large variation in hospital infection rates across the UK, with the worst performers having more than 5 times the number of cases than the best performing hospitals.

As part of their ongoing effort to combat HCAIs, Royal Manchester Children’s Hospital (RMCH) recently added the Surfacide Helios Ultraviolet C (UV-C) Disinfection System to its cleaning protocol. The Helios system is a triple-emitter UV-C hard surface disinfection system that eradicates multi-drug resistant organisms in the patient environment.

RMCH is the very first hospital within the NHS and the UK turning to UV-C technology as a complement to traditional cleaning methods. The hospital will be deploying four UV-C disinfection systems (12 emitters) throughout the hospital to protect patients and staff. This UV-C system uses three light emitting towers to safely and effectively disinfect all areas of a hospital room including tough to reach areas like bathrooms.

RMCH conducted an independent pilot study using the UV-C disinfection system in the hospital’s oncology/hematology unit. The eight-month independent study compared standard cleaning protocols alone to those including Surfacide Helios UV-C Disinfection. The result was an 83.7 percent decrease in contaminated sites and a 43 percent decrease in HAIs when the Helios system was introduced into the patient environment along with standard cleaning procedures. The Helios system was effective at reducing and eliminating a variety of drug-resistant microorganisms and has been shown to eradicate multi-drug resistant organisms, including C.Diff, MRSA, VRE, CRE and Acinetobacter.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X